Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DNLI · against 1,216 other Healthcare companies
Ranked #1,066 of 1,217 · scores higher than 12% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 10–19, including DNLI · Click a bar to see the companies
Mainly because of its 3-year revenue growth, which is weaker than most Healthcare peers.
| Metric | DNLI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | Not reported | 6.1% | — | — | 33% |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -78.1% | 5.8% | 0% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,066 | 2.9B CNY (≈$411M) | 12 | 23 | |
| 1,066 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 7.2B CNY (≈$1.0B) |
| 12 |
| 51 |
| 1,066 | 3.5B CNY (≈$496M) | 12 | 18 |
| 1,066 | 14.2B CNY (≈$2.0B) | 12 | 10 |
| 1,066 | 3.1B USD | 12 | 27 |
| 1,078 | 3.3B CNY (≈$468M) | 11 | 20 |
| 1,078 | 29.2B CNY (≈$4.1B) | 11 | 42 |
| 1,078 | 3.1B CNY (≈$437M) | 11 | 46 |
| 1,078 | 105.8B KRW (≈$76M) | 11 | 41 |